| Market Cap | ₹359Cr | 
| ROE | -11.89% | 
| P/E Ratio(TTM) | -2.00 | 
| EPS(TTM) | -8.02 | 
| P/B Ratio | 0.38 | 
| Dividend Yield | 0.00% | 
| Industry P/E | 34.73 | 
| Book Value | 42.63 | 
| Debt to Equity | 0.61 | 
| Face Value | 1 | 
| Parent Organisation | Nectar Life Sciences | 
| Managing Director | Mr. Sanjiv Goyal | 
| NSE Symbol | NECLIFE | 
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 91.44 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.79 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.00 | ||
| Wockhardt | NA (0.00%) | -142.48 |